Cancer has touched us all at some point in time or another. Whether it’s directly or indirectly, most people have dealt with the disease at least once in a lifetime. This is the situation that Clay Siegall has dealt with. Clay Siegall is one of the most respected individuals in cancer research. When he was in college, a close family member became stricken with the illness. Cancer had a detrimental effect on this person’s body, which left Siegall heartbroken. Though he has always had an interest in the medical industry, this was the straw that broke the camel’s back.
As time went on, Siegall earned a Ph.D in Genetics as well as a B.S. Zoology. These degrees were simply the foundation of what was to come. This extraordinary guy worked with industry pharmaceutical companies by the names of GlaxoSmithKline, Genentech, Bayer and Pfizer throughout the years. By 1998, Siegall was ready to take a step forward, and this step forward just so happened to be the birth of Seattle Genetics. Located in Bothell, Washington, this small oncology company went to work in the cancer research field. After getting over the hump, it began to flourish thanks to its wide range of cancer therapies. Siegall had found his weapon of choice, and it was being used to better society. Thanks to its scientific innovations and drug development capabilities, the company introduced its ADCETRIS drug. This drug would go on to become one of the best cancer fighting medications of the 21st century.
Being so well-versed in this exclusive line of work. Siegall has been able to write up to 70 publications, and he is the current holder of 15 patents. Nothing is taken for granted and nothing is left to chance. Rigorous research goes into each and every product, which ensures the patients of the very best and safety of its medications. Dr. Clay Siegall is definitely on a mission, but only time will tell what the coming years have in store.